The expression and function of androgen receptor coactivator p44 and protein arginine methyltransferase 5 in the developing testis and testicular tumors - PubMed (original) (raw)
. 2007 May;177(5):1918-22.
doi: 10.1016/j.juro.2007.01.017.
Zhengxin Wang, Luis Chiriboga, M Alba Greco, Ellen Shapiro, Hongying Huang, Ximing J Yang, Jiaoti Huang, Yi Peng, Jonathan Melamed, Michael J Garabedian, Peng Lee
Affiliations
- PMID: 17437848
- DOI: 10.1016/j.juro.2007.01.017
The expression and function of androgen receptor coactivator p44 and protein arginine methyltransferase 5 in the developing testis and testicular tumors
John J Liang et al. J Urol. 2007 May.
Abstract
Purpose: The role of androgen receptor coactivators in testicular development and cancer formation is unclear. p44/Mep50 was identified as an androgen receptor coactivator that functions in a complex with protein arginine methyltransferase 5. We studied the expression of p44 and protein arginine methyltransferase 5 in developing fetal testis and adult testicular tumors, including seminomas and Leydig cell tumors.
Materials and methods: A total of 30 human fetal testes from abortuses at a gestational age of 10 to 40 weeks, 33 human seminomas and 11 human Leydig cell tumors were retrieved from the archives of the departments of pathology. Immunohistochemistry was performed with affinity purified p44 and IgG purified protein arginine methyltransferase 5 polyclonal antibodies.
Results: Protein arginine methyltransferase 5 and p44 were expressed predominantly as nuclear proteins in fetal Leydig cells and human adult nonneoplastic testes, including germ cells and Leydig cells, while they were expressed in the cytoplasm of germ cells of the fetal testis. Expression was strongest in the fetal testis during the second trimester. Compared to adult nonneoplastic testes, human seminoma and Leydig tumor cells showed a marked decrease in nuclear expression of p44 and protein arginine methyltransferase 5 with a concomitant marked increase in cytoplasmic expression of these proteins. Furthermore, average testicular size was increased by 29% in p44(+/-) heterzygotic mice.
Conclusions: These results suggest distinct functions of the nuclear and the p44/protein arginine methyltransferase 5 complexes in the developing fetal testis and in the oncogenesis of testicular tumors. Further studies are needed to confirm the functional relevance of these findings.
Similar articles
- Estrogen receptor-beta expression in human testicular germ cell tumors.
Pais V, Leav I, Lau KM, Jiang Z, Ho SM. Pais V, et al. Clin Cancer Res. 2003 Oct 1;9(12):4475-82. Clin Cancer Res. 2003. PMID: 14555521 - The cancer-testis gene, NY-ESO-1, is expressed in normal fetal and adult testes and in spermatocytic seminomas and testicular carcinoma in situ.
Satie AP, Rajpert-De Meyts E, Spagnoli GC, Henno S, Olivo L, Jacobsen GK, Rioux-Leclercq N, Jégou B, Samson M. Satie AP, et al. Lab Invest. 2002 Jun;82(6):775-80. doi: 10.1097/01.lab.0000017169.26718.5f. Lab Invest. 2002. PMID: 12065688 - Novel germ cell markers characterize testicular seminoma and fetal testis.
Gashaw I, Dushaj O, Behr R, Biermann K, Brehm R, Rübben H, Grobholz R, Schmid KW, Bergmann M, Winterhager E. Gashaw I, et al. Mol Hum Reprod. 2007 Oct;13(10):721-7. doi: 10.1093/molehr/gam059. Epub 2007 Sep 4. Mol Hum Reprod. 2007. PMID: 17785371 - Testicular and testicular adnexa tumors in the elderly.
Gigantino V, La Mantia E, Franco R, Cecere S, Rossetti S, Di Napoli M, Pisano C, Berretta M, Galzerano A, Botti G, Pignata S, Facchini G. Gigantino V, et al. Anticancer Drugs. 2013 Mar;24(3):228-36. doi: 10.1097/CAD.0b013e32835a3598. Anticancer Drugs. 2013. PMID: 23059385 Review. - An in-depth look at Leydig cell tumor of the testis.
Al-Agha OM, Axiotis CA. Al-Agha OM, et al. Arch Pathol Lab Med. 2007 Feb;131(2):311-7. doi: 10.5858/2007-131-311-AILALC. Arch Pathol Lab Med. 2007. PMID: 17284120 Review.
Cited by
- LKB1 regulates PRMT5 activity in breast cancer.
Lattouf H, Kassem L, Jacquemetton J, Choucair A, Poulard C, Trédan O, Corbo L, Diab-Assaf M, Hussein N, Treilleux I, Le Romancer M. Lattouf H, et al. Int J Cancer. 2019 Feb 1;144(3):595-606. doi: 10.1002/ijc.31909. Epub 2018 Oct 31. Int J Cancer. 2019. PMID: 30289978 Free PMC article. - Yeast two-hybrid screening identified WDR77 as a novel interacting partner of TSC22D2.
Li Q, Chen P, Zeng Z, Liang F, Song Y, Xiong F, Li X, Gong Z, Zhou M, Xiang B, Peng C, Li X, Chen X, Li G, Xiong W. Li Q, et al. Tumour Biol. 2016 Sep;37(9):12503-12512. doi: 10.1007/s13277-016-5113-z. Epub 2016 Jun 23. Tumour Biol. 2016. PMID: 27337956 - Overexpression of PRMT5 promotes tumor cell growth and is associated with poor disease prognosis in epithelial ovarian cancer.
Bao X, Zhao S, Liu T, Liu Y, Liu Y, Yang X. Bao X, et al. J Histochem Cytochem. 2013 Mar;61(3):206-17. doi: 10.1369/0022155413475452. Epub 2013 Jan 4. J Histochem Cytochem. 2013. PMID: 23292799 Free PMC article. - The Year in Basic Thyroid Cancer Research.
Di Cristofano A. Di Cristofano A. Thyroid. 2022 Jan;32(1):3-8. doi: 10.1089/thy.2021.0561. Epub 2021 Dec 16. Thyroid. 2022. PMID: 34806425 Free PMC article. - JAK2V617F-mediated phosphorylation of PRMT5 downregulates its methyltransferase activity and promotes myeloproliferation.
Liu F, Zhao X, Perna F, Wang L, Koppikar P, Abdel-Wahab O, Harr MW, Levine RL, Xu H, Tefferi A, Deblasio A, Hatlen M, Menendez S, Nimer SD. Liu F, et al. Cancer Cell. 2011 Feb 15;19(2):283-94. doi: 10.1016/j.ccr.2010.12.020. Cancer Cell. 2011. PMID: 21316606 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases